Researchers in Australia create long lasting surface spray to kill infectious pathogens

A team of researchers at University of Queensland (UQ), Australia has developed a long lasting surface spray that has th...

January 18, 2023 | Wednesday | News
Global Young Scientists Summit (GYSS) kickstarts in Singapore

The 11th edition of Global Young Scientists Summit (GYSS) kick-starts in Singapore to explore various science sectors be...

January 17, 2023 | Tuesday | Company results
Singapore unveils talent development strategy to boost Healthtech and Biotech ecosystem

SGInnovate, a Deep Tech ecosystem builder and investor backed by the Singapore government, has launched Deep Tech Talent...

January 17, 2023 | Tuesday | News
Japan's Astellas Pharma inks $340 M worth deal to advance gene therapy portfolio

US-based Selecta Biosciences, and Japanese firm Astellas Pharma have announced an exclusive licensing and development ag...

January 16, 2023 | Monday | News
Ajinomoto and Exelixis partner to develop novel antibody-drug conjugates for cancer treatment

Japan-based Ajinomoto has announced a license agreement with US-based firm Exelixis to incorporate AJICAP, Ajinomoto Co....

January 11, 2023 | Wednesday | News
AstraZeneca partners with Australia-based LBT for new pharmaceutical product line

Australian medical technology company LBT Innovations, a leader in medical technology automation using artificial ...

January 10, 2023 | Tuesday | News
Propelling Genomic Research with Future-Proof Digital Infrastructure

Digital transformation in healthcare has been at breakneck speed since the outbreak of COVID-19. It took just a year to ...

January 6, 2023 | Friday | Opinion
“Our ambition requires us to take long-term view, investing in scale and building unmatched capabilities”

A study by Grand View Research reveals that the global single-cell analysis market size was valued at $3.28 billion in 2...

January 6, 2023 | Friday | News
"Innovations that serve a purpose, paired with a good go-to-market strategy are attractive for VCs"

In 2016, the Singapore government committed to a S$4 billion budget to drive research and commercialisation activities i...

January 6, 2023 | Friday | Opinion
Moderna buys Japanese startup OriCiro for $85M

Moderna, a US-based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and OriCiro Genomic...

January 9, 2023 | Monday | News
Health technology assessments, cell and gene therapies to rule in 2023

Governments and other payers make decisions in the context of the broader economic environment. For 2023 we will continu...

January 6, 2023 | Friday | Opinion
Biocytogen and Hansoh Pharma announce antibody license agreement in China

Biocytogen Pharmaceuticals and Hansoh Pharmaceutical Group have announced an antibody collaboration, assignment and excl...

January 3, 2023 | Tuesday | News
South Korea's Alteogen partners with Sandoz AG for biosimilars

South Korean firm Alteogen Inc has entered into an exclusive license agreement with Sandoz AG. Under the terms of t...

January 4, 2023 | Wednesday | News
Mission Bio, Abiosciences to co-develop bioinformatics for clinical research applications in China

US-based Mission Bio and Abiosciences have announced a new partnership to co-develop bioinformatics packages for transla...

December 30, 2022 | Friday | News
Japanese startup Veritas In Silico inks new partnership for mRNA-targeted small molecule drug discovery

Japan-based startup Veritas In Silico has entered into a joint drug discovery research agreement with RaQualia Pharma to...

December 30, 2022 | Friday | News
Japanese pharma firm PeptiDream inks $3 B worth deals for novel peptide drug conjugates

PeptiDream Inc., , Japan-based biopharmaceutical company, has announced new multi-target collaboration and license agree...

December 28, 2022 | Wednesday | News
Korean firm LegoChem Biosciences inks $1.25 B research collaboration with Amgen

South Korea-based LegoChem Biosciences, Inc. (LCB) has entered into a research collaboration and license agree...

December 26, 2022 | Monday | News
Australia raises concerns over lack of research funding for treating oral disorders

Major government research funding schemes aren’t keeping up with the burden of oral diseases, according to a new s...

December 23, 2022 | Friday | News
Merck, Kelun-Biotech ink $9.3 B licensing pact for seven cancer candidates in China

Merck, and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical in China), a clinical-stage biotech compa...

December 23, 2022 | Friday | News
Takeda, IIF, and Mitsubishi further develop Shonan iPark in Japan to enhance life sciences ecosystem

Renewing its commitment to innovation in Japan and to Shonan Health Innovation Park (Shonan iPark), Japan-based Takeda P...

December 22, 2022 | Thursday | News
BioNTech activates clinical trial hub in Taiwan for mRNA-based cancer immunotherapies

German firm BioNTech SE has announced plans to accelerate and broaden the clinical development of its can...

December 21, 2022 | Wednesday | News
Korea's Amorepacific inks beauty research agreement with Johns Hopkins University

Amorepacific Corporation, a South Korean beauty and cosmetics conglomerate, has announced its successful execution of a ...

December 21, 2022 | Wednesday | News
SGInnovate unravels opportunities and challenges at Singapore's biotech sector

Singapore's innovation platform SGInnovate, which supports deep technology entrepreneurship has unraveled a report on op...

December 19, 2022 | Monday | Analysis
Researchers identify ‘born to be bad' colorectal cancer tumours

An international research team has identified ‘born to be bad’ colorectal tumours in people with early stage...

December 19, 2022 | Monday | News
EnterpriseSG launches Singapore Global Executive Programme (SGEP) to foster start-ups

The SGEP – driven by Enterprise Singapore will contribute to the Government’s Enterprise 2030 ...

December 19, 2022 | Monday | News